相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis
Bo Shi et al.
ISCIENCE (2021)
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Ciaran P. Kelly et al.
GASTROENTEROLOGY (2021)
Monocytes prime autoreactive T cells after myocardial infarction
Matthew DeBerge et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Intravenous Immunomodulatory Nanoparticle Treatment for Traumatic Brain Injury
Sripadh Sharma et al.
ANNALS OF NEUROLOGY (2020)
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients
Lorenzo Beretta et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Understanding the impact of fibroblast heterogeneity on skin fibrosis
Michelle F. Griffin et al.
DISEASE MODELS & MECHANISMS (2020)
Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma
Marta Bueno et al.
CURRENT RHEUMATOLOGY REPORTS (2020)
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
Taylor S. Adams et al.
SCIENCE ADVANCES (2020)
Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis
Arun C. Habermann et al.
SCIENCE ADVANCES (2020)
Emerging targets of disease-modifying therapy for systemic sclerosis
Elizabeth R. Volkmann et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Inhibition of MARCO ameliorates silica-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition
Meng Yang et al.
TOXICOLOGY LETTERS (2019)
Macrophages in Systemic Sclerosis: Novel Insights and Therapeutic Implications
Diana M. Toledo et al.
CURRENT RHEUMATOLOGY REPORTS (2019)
Senescence signature in skin biopsies from systemic sclerosis patients treated with senolytic therapy: potential predictor of clinical response?
Viktor Martyanov et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
Christina Morse et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Rationally-based therapeutic disease modification in systemic sclerosis: Novel strategies
Yoshihide Asano et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Transcriptional regulatory model of fibrosis progression in the human lung
John E. McDonough et al.
JCI INSIGHT (2019)
Role of STAT3 in skin fibrosis and transforming growth factor beta signalling
Mesias Pedroza et al.
RHEUMATOLOGY (2018)
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
Jessica K. Gordon et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Defining Impaired Respiratory Health A Paradigm Shift for Pulmonary Medicine
Paul A. Reyfman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk
Aida Moreno-Moral et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Immunology and systemic sclerosis - Editorial
Steven O'Reilly et al.
IMMUNOLOGY LETTERS (2018)
Dendritic cells in systemic sclerosis: Advances from human and mice studies
Alsya J. Affandi et al.
IMMUNOLOGY LETTERS (2018)
Toll Like Receptors in systemic sclerosis: An emerging target
Steven O'Reilly
IMMUNOLOGY LETTERS (2018)
Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy
Dan Xu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging
Eduardo N. Chini et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Baseline Plasma Cell Gene Signature Predicts Improvement in Systemic Sclerosis Skin Scores Following Treatment With Inebilizumab (MEDI-551) and Correlates With Disease Activity in Systemic Lupus Erythematosus and Chronic Obstructive Pulmonary Disease
Katie Streicher et al.
ARTHRITIS & RHEUMATOLOGY (2018)
TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung
Swati Bhattacharyya et al.
JCI INSIGHT (2018)
Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice
Su Ji Jeong et al.
NEUROBIOLOGY OF DISEASE (2017)
Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities
John Varga et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Mesenchymal Stem Cells in Fibrotic Disease
Elie El Agha et al.
CELL STEM CELL (2017)
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Thomas A. Wynn et al.
IMMUNITY (2016)
The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis
Ido Amit et al.
NATURE IMMUNOLOGY (2016)
SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
Kaname Akamata et al.
ONCOTARGET (2016)
Redox mechanisms in age-related lung fibrosis
Ashish Kurundkar et al.
REDOX BIOLOGY (2016)
Sirt1 regulates canonical TGF-beta signalling to control fibroblast activation and tissue fibrosis
Pawel Zerr et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Update on macrophages and innate immunity in scleroderma
Jennifer J. Chia et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure
Shubha Murthy et al.
FASEB JOURNAL (2015)
Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis
Katherine G. MacDonald et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways
Lara Bossini-Castillo et al.
JOURNAL OF AUTOIMMUNITY (2015)
Genetics of systemic sclerosis
Lara Bossini-Castillo et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms
J. Matthew Mahoney et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling
Jun Wei et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Macrophages During the Fibrotic Process: M2 as Friend and Foe
Tarcio Teodoro Braga et al.
FRONTIERS IN IMMUNOLOGY (2015)
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Suzana Jordan et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Therapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles
Daniel R. Getts et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
FibronectinEDA Promotes Chronic Cutaneous Fibrosis Through Toll-like Receptor Signaling
Swati Bhattacharyya et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Fibroblasts in fibrosis: novel roles and mediators
Ryan T. Kendall et al.
FRONTIERS IN PHARMACOLOGY (2014)
Mechanisms regulating skin immunity and inflammation
Manolis Pasparakis et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-β Responses A Novel Mechanism for Maintaining and Amplifying Fibrosis in Scleroderma
Swati Bhattacharyya et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Macrophage biology in development, homeostasis and disease
Thomas A. Wynn et al.
NATURE (2013)
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Swati Bhattacharyya et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis
Michael A. Gibbons et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Vascular Changes in Bleomycin-Induced Scleroderma
Toshiyuki Yamamoto et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2011)
Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity
Gleb Slobodin et al.
CELLULAR IMMUNOLOGY (2010)
Endothelial/lymphocyte activation leads to prominent CD4+T cell infiltration in the gastric mucosa of patients with systemic sclerosis
Mirko Manetti et al.
ARTHRITIS AND RHEUMATISM (2008)
A murine scavenger receptor MARCO recognizes polystyrene nanoparticles
Sanae Kanno et al.
TOXICOLOGICAL SCIENCES (2007)
B cell infiltration in systemic sclerosis-associated interstitial lung disease
Robert Lafyatis et al.
ARTHRITIS AND RHEUMATISM (2007)
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
Paul A. Yushkevich et al.
NEUROIMAGE (2006)
MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages
MS Arredouani et al.
JOURNAL OF IMMUNOLOGY (2005)
Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: Cutaneous cytokines, chemokines, and immune cell activation
Y Zhang et al.
JOURNAL OF IMMUNOLOGY (2002)
Protection from pulmonary fibrosis in the absence of CCR2 signaling
BB Moore et al.
JOURNAL OF IMMUNOLOGY (2001)